In our study, we evaluated the immunohistochemical (IHC) expression of p63 and p53 in DLBCL and correlated between the level of expression and other clinicopathological parameters to determine their effect on overall and progression free survival. Here, TP53 is linked to diffuse large B-cell lymphoma.